Published in Virchows Arch on November 05, 2014
Down-regulation of BRMS1 by DNA hypermethylation and its association with metastatic progression in triple-negative breast cancer. Int J Clin Exp Pathol (2015) 0.78
Pan-cancer analyses of the nuclear receptor superfamily. Nucl Receptor Res (2015) 0.78
In this issue. Virchows Arch (2015) 0.75
Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue. Virchows Arch (2017) 0.75
Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res (2004) 3.29
Interplay between the cancer genome and epigenome. Cell (2013) 3.05
Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res (2007) 2.02
DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer. Genome Res (2011) 1.85
Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer. Mod Pathol (2007) 1.71
Multifocal prostate cancer: biologic, prognostic, and therapeutic implications. Hum Pathol (2010) 1.61
Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins. Eur Urol (2012) 1.60
Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing. Dis Markers (2011) 1.56
Testing mutual exclusivity of ETS rearranged prostate cancer. Lab Invest (2010) 1.48
Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression. Cancer Res (2000) 1.32
Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy. Clin Cancer Res (2005) 1.30
PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade. Mod Pathol (2012) 1.26
Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression. Int J Cancer (2011) 1.25
CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Urology (2008) 1.24
Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma. Cancer (1998) 1.18
Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens. Prostate (2004) 1.15
8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects. Clin Cancer Res (2006) 1.11
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res (2004) 1.05
Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomas. Am J Pathol (2002) 1.04
Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol (2007) 1.04
DNA methylation changes in prostate cancer. Methods Mol Biol (2012) 1.00
High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer. Genes Chromosomes Cancer (2012) 0.96
Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm. Virchows Arch (2008) 0.94
Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer. Neoplasia (2013) 0.90
Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis. Br J Urol (1991) 0.89
Molecular analysis of multifocal prostate cancer by comparative genomic hybridization. Prostate (2008) 0.87
Genome-wide investigation of multifocal and unifocal prostate cancer-are they genetically different? Int J Mol Sci (2013) 0.85
DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancer. Anticancer Res (2013) 0.85
DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer. DNA Cell Biol (2011) 0.82
Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: quantitative pyrosequencing analysis. J Biomol Screen (2012) 0.77
CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer. Genes Chromosomes Cancer (2005) 1.38
Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data. Diagn Pathol (2012) 1.32
Considerations on implementing diagnostic markers into clinical decision making in bladder cancer. Urol Oncol (2010) 1.12
Standards and specifications in pathology: image management, report management and terminology. Stud Health Technol Inform (2012) 1.11
A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue. Breast Cancer Res (2014) 1.10
Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer. Int J Cancer (2003) 1.09
Digital pathology evaluation of complement C4d component deposition in the kidney allograft biopsies is a useful tool to improve reproducibility of the scoring. Diagn Pathol (2011) 1.06
Epigenetic markers of prostate cancer in plasma circulating DNA. Hum Mol Genet (2012) 0.99
Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure. Mutagenesis (2012) 0.95
Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer. Oncology (2008) 0.93
Non-linear optical microscopy of kidney tumours. J Biophotonics (2013) 0.88
Ocular surface reconstruction using amniotic membrane following excision of conjunctival and limbal tumors. Eur J Ophthalmol (2011) 0.88
Slow progressive FSGS associated with an F392L WT1 mutation. Pediatr Nephrol (2004) 0.87
Quantification of myocardial fibrosis by digital image analysis and interactive stereology. Diagn Pathol (2014) 0.87
Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study. J Cancer Res Clin Oncol (2009) 0.85
Prognostic significance of peripheral blood CD8highCD57+ lymphocytes in bladder carcinoma patients after intravesical IL-2. Anticancer Res (2011) 0.84
Combined analysis of TMPRSS2-ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer. Genes Chromosomes Cancer (2012) 0.83
SNOMED CT in pathology. Stud Health Technol Inform (2012) 0.83
Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas. Cancer Genet (2011) 0.83
Sulforaphane decreases kidney injury after transplantation in rats: role of mitochondrial damage. Ann Transplant (2013) 0.82
A data model for handling whole slide microscopy images in picture archiving and communications systems. Stud Health Technol Inform (2009) 0.80
Correction: Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer. PLoS One (2015) 0.78
Nationwide renal biopsy data in Lithuania 1994-2012. Int Urol Nephrol (2015) 0.78
Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma. J Neuropathol Exp Neurol (2007) 0.77
Digital immunohistochemistry platform for the staining variation monitoring based on integration of image and statistical analyses with laboratory information system. Diagn Pathol (2014) 0.77
Evaluation of the biological activity of naturally occurring 5,8-dihydroxycoumarin. Molecules (2013) 0.77
Prognostic value of O-6-methylguanine-DNA methyltransferase loss in salivary gland carcinomas. Head Neck (2013) 0.77
[The prevalence of Fabry's disease among male patients on hemodialysis in Lithuania (a screening study)]. Medicina (Kaunas) (2007) 0.77
Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer. Medicina (Kaunas) (2011) 0.76
[Primary glomerulopathies in Lithuania: a retrospective analysis of renal biopsy cases (2000-2006)]. Medicina (Kaunas) (2007) 0.76
Infrared spectroscopic imaging of renal tumor tissue. J Biomed Opt (2011) 0.76
Digital immunohistochemistry wizard: image analysis-assisted stereology tool to produce reference data set for calibration and quality control. Diagn Pathol (2014) 0.76
Extremely low risk of pheochromocytomas in complete VHL gene deletion cases. Hum Mutat (2009) 0.75
Dementia and art: neuronal intermediate filament inclusion disease and dissolution of artistic creativity. Eur Neurol (2007) 0.75
Unilateral hydronephrosis and renal damage after acute leukemia. Case Rep Med (2012) 0.75
[Use of strontium-89 in the analgesic treatment of cancer patients with bone metastases]. Medicina (Kaunas) (2006) 0.75
Comprehensive Immunohistochemistry: Digital, Analytical and Integrated. Pathobiology (2016) 0.75
[Prostatic biopsy technique. Historical review]. Medicina (Kaunas) (2005) 0.75
[Models of intracranial aneurysms for angiographic imaging modalities. A technical note]. Medicina (Kaunas) (2007) 0.75
Nephron sparing surgery in renal cancer--individual decision or standard procedure? Actas Urol Esp (2003) 0.75
[The indications of renal biopsies and spectrum of renal diseases in five nephrological centers of Lithuania (a five-year study)]. Medicina (Kaunas) (2003) 0.75
The First Congress of the International Academy of Digital Pathology: digital pathology comes of age. Anal Cell Pathol (Amst) (2012) 0.75
[Bladder preservation possibilities in the treatment of muscle-invasive bladder cancer]. Medicina (Kaunas) (2006) 0.75
Spontaneous and benzo[a]pyrene-induced micronuclei in the embryos of the black-headed gull (Larus ridibundus L.). Mutat Res (2003) 0.75
[Prognosis of chronic renal failure in patients with membranous nephropathy]. Medicina (Kaunas) (2003) 0.75
The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer. Medicina (Kaunas) (2010) 0.75
[Nephrotoxicity of cyclosporin A after kidney transplantation]. Medicina (Kaunas) (2003) 0.75